Nationwide registry for systemic autoimmune and autoinflammatory diseases in Armenia
Official title: Armenian Nationwide Registry of Systemic Autoimmune and Autoinflammatory Diseases
Run by Santé Arménie French-Armenian Research Center · NCT05904301 · Data updated 2026-11-12
This study is trying to gather information about systemic autoimmune and autoinflammatory diseases in Armenia to better understand how these conditions progress and how they are treated.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 800 (estimated) |
| Sponsor | Santé Arménie French-Armenian Research Center Academic / other |
| Locations | 6 sites (Yerevan and 5 other locations) |
| Status | Recruiting |
| Started | June 21, 2023 |
| Main results expected | June 30, 2028 |
| Study ends | June 30, 2028 |
| Registry record updated | April 8, 2025 |
| Trial ID | NCT05904301 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients with a confirmed diagnosis of specific autoimmune systemic diseases such as Behcet disease, ANCA-positive vasculitis, and Sjogren's syndrome.
✕Probably not a fit
Patients who are breastfeeding or pregnant, or those who refuse to participate, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to create a longitudinal prospective registry of systemic autoimmune and autoinflammatory diseases in Armenia, focusing on conditions such as Behcet Disease and ANCA-positive vasculitis. The registry will involve the usual medical management of patients along with the collection of additional blood and stool samples for biobanking. By documenting the epidemiological elements and treatment variations across different centers, the study seeks to enhance understanding and management of these complex diseases. The initiative is expected to contribute valuable data on disease progression and treatment outcomes.
Why it matters
Potential benefit: If successful, this registry could improve the understanding and management of systemic autoimmune diseases, leading to better patient outcomes.
How similar studies have gone: While similar registries have been established in other regions, this specific approach in Armenia is novel and aims to fill a significant knowledge gap.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients with a confirmed diagnosis of at least one of following autoimmune systemic diseases: Behcet disease, ANCA -positive vasculitis, Takayasu arteritis, Giant cell arteritis, Systemic sclerosis, Sjogren syndrome, Rheumatoid arthritis, Spondylarthritis (psoriatic, ankylosing, crohn's related), Angioedema hereditary and acquired, Pediatric dermatology, Autoinflammatory diseases (hereditary and acquired), Unexplained infertility, Immune thrombocytopenic purpura/ Autoimmune hemolytic anemia (ITP, AHA), Primary anti-phospholipid syndrome (APS), Celiac disease. 2. Age: major and minor 3. Patients who have been informed and provided with written informed consent to participate Or consent from legal representative Exclusion Criteria: 1. Patients refusing to participate in the registry 2. Non-consent from legal representative 3. Breastfeeding or pregnant patients
Where it's running
-
Hematology Center after Prof.R.H. Yeolyan
Yerevan, Armenia Recruiting -
Nairi Medical Center, Rheumatology Department
Yerevan, Armenia Recruiting -
Heratsi Hospital Complex №1, Allergology Department
Yerevan, Armenia Recruiting -
Mikaelyan Institute of Surgery, Rheumatology Department
Yerevan, Armenia Recruiting -
Heratsi Hospital Complex n°1, Rheumatology Department
Yerevan, Armenia Not yet recruiting -
Erebouni Medical Center, Rheumatology Department
Yerevan, Armenia Not yet recruiting
Study contacts
- Study coordinator: Arsene Mekinian, Prof.
- Email: arsene.mekinian@aphp.fr
- Phone: 01 49 28 23 92
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Registry and biorepository for rheumatic diseases
This study is collecting samples and health information from adults with rheumatic diseases at Yale clinics to help researchers learn more about these conditions and improve future treatments.
-
Imaging in Inflammatory Heart Diseases linked to autoimmune disorders
This study tests how well multimodality imaging (CMR, echocardiography, and PET) detects inflammation in people with suspected inflammatory heart or autoimmune rheumatic diseases.
-
Pain patterns in rheumatic diseases: see if pain works differently in patients and healthy people
This observational study tests how pain is experienced and measured in people with rheumatic diseases compared with healthy volunteers.
-
First-in-human test of CND319 in healthy people and people with rheumatic diseases
This early study tests whether CND319 is safe and tolerable and whether it shows any signs of activity in healthy adults and in people with rheumatoid arthritis or Sjogren's syndrome.
-
Creating Health online course for people with rheumatological conditions
This project will test whether an online course about diet and self-care helps adults with rheumatoid arthritis, Sjogren's syndrome, lupus, mixed connective tissue disease, or psoriatic arthritis reduce fatigue and improve quality of life.
-
Study on how diet affects autoimmune diseases in rheumatology patients
This study looks at how changing to a healthier diet, like the Mediterranean diet, might help people with autoimmune diseases feel better and manage their symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.